Amanda Min Hui Choo
Yee Siang Ong2
Fadi Issa- 1Ministry of Health, Singapore, Singapore
- 2Department of Plastics, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore, Singapore
- 3Department of Plastic Surgery and Burns, Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom
- 4Medical Sciences Division, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
Healing after dermal injury is a complex but imperfect process that results in a wide range of visible scars. The degree of disfigurement is not the sole determinant of a scar's effect on patient well-being, with a number of other factors being critical to outcome. These include cosmetic appearance, symptoms such as itch and pain, functional loss, psychological or social problems, and quality of life. An accurate assessment of these domains can help clinicians measure outcomes, develop, and evaluate treatment strategies. A PubMed literature search was performed up to 31st March 2020. Ten objective scar measurements, four Clinician-Reported Outcome Measures (CROMs), six Patient-Reported Outcome Measures (PROMs), and one combined measure were evaluated for their reliability, clinical relevance, responsiveness to clinical change, and feasibility. Many quantitative tools were limited in their clinical relevance and feasibility, whereas few qualitative CROMs and PROMs have undergone rigorous assessment. This review examines currently available assessment tools, focusing primarily on subjective scar measurements (CROMs, PROMs), and offers a perspective on future directions in the field.
Introduction
What Is a Scar?
A scar is the macroscopic disturbance of the normal structure and function of skin, formed following the maturation phase of wound healing (1, 2). An immature scar may initially be pink, hard, raised, and itchy, before maturing over 1–2 years into a paler, softer, flatter, and less itchy lesion. It can be described as atrophic, hypertrophic, and keloid. Linear scars form the largest category of surgical scars, while burn scars are often the most cosmetically and functionally problematic, often due to their traumatic nature, inconsistent pattern, and area (3).
Why Assess Scars?
A patient's overall satisfaction with wound healing is significantly influenced by the resulting scar. Not only are scars the apparent cosmetic outcome of surgery or injury, but they can also contribute to functional problems. These include movement restrictions that can affect even basic tasks of breathing, eating and speaking. Less visible but important issues include pruritus, pain, and psychosocial sequelae. A scar assessment tool allows the surgeon to consolidate these outcomes. Standardised scales are useful to monitor changes in scar quality over time and to compare scars and the outcome of treatment. The evidence base for scar therapy is limited by the infrequent use of standardised assessment tools across different scar therapies (4). Hence, a holistic and valid assessment tool is essential to ensure progress in wound healing and scar treatment.
Creating Scar Assessment Tools
Assessment tools must apply a rigorous approach involving patient and clinician input, a pre-test evaluation, modification, and finally application to a target population. A useful assessment tool should be:
- Clinically relevant: It should include items that are important to patients, clinicians, and researchers (content validity)
- Reliable: For the tool to be used in large and multiple studies, the same scar should obtain the same results between different raters (inter-rater reliability) or subsequent evaluations by the same rater (intra-rater reliability). Quantitatively this can be expressed as the Intraclass Correlation Coefficient (ICC) or Kappa coefficient (κ)
- Responsive: If clinicians are to use the tool to assess patients' scars over time or after treatment, the tool should be able to detect these changes. This can be represented by the T-statistic, effect size (ES), Guyatt's responsiveness statistic (GRS), or standardised response mean (SRM)
- Feasible: The target audience (including patients, clinicians, and researchers) should be able to use the tool efficiently and cost-effectively, and easily interpret the results.
Methods
A literature search was performed in PubMed up to 31st March 2020. The search terms included “(scar assessment tools),” “(scar) and (patient-reported outcome measure),” “(scar) and (clinician-reported outcome measure).” Original studies, literature reviews, and systematic reviews written in English (quantitative and qualitative) were included. Tools that assess surgical, traumatic, and burn scars were identified. The tools could be objective measurements, Clinician-Reported Outcome Measures (CROMs), Patient-Reported Outcome Measures (PROMs), or combined measures that include both clinician- and patient-reported outcome measures. Articles that evaluated effectiveness of scar management therapies were not included. A total of 426 articles were identified, and among these, 21 tools were included: 10 objective scar measurements, four CROMs, six PROMs, and one combined measure. The tools were then evaluated for their reliability, clinical relevance, responsiveness to clinical change, and feasibility (as reported in the literature).
Current Clinical Assessment Tools
Objective Scar Measurements
Scar measurements most frequently studied in clinical trials (5) are colour (vascularisation and pigmentation), thickness (height: clinical and histological), relief (surface irregularities), pliability (tissue elasticity), and surface area (scar contraction or expansion). The reliability, validity, and responsiveness of these tools are summarised in Table 1A. While these measurements might be seen as an objective and quantifiable way to assess scars, none of the available tools combine clinical relevance and feasibility. Further details of these objective scar measurement tools available are found in Supplementary Materials.
Table 1A. Reliability, validity, and responsiveness of existing assessment tools, as reported in the literature reviewed.
Clinician-Reported Outcome Measures (CROMs)
One of the first scar assessment scales was created in 1988 in a burns institute in Boston to measure burn-induced cosmetic disfigurement (6). Colour-slide photographs of 30 burn patients were shown to 95 clinical and non-clinical observers who rated scar irregularity, thickness, discolouration, and overall cosmetic disfigurement.
- Reliability: The study demonstrated that a panel of four to eight observers with at least some experience with burn patients could produce reliable average ratings of burn scars (6).
- Feasibility: The requirement of at least four observers is not feasible in a clinical setting.
Subsequently, a Wound Evaluation Scale was developed to assess repaired lacerations (7). This was a six-item, dichotomous categorical scale.
- Clinical relevance: Unfortunately, the assessed variables reflect surgical attributes rather than scar appearance, and have less relevance to patients or clinicians.
Eventually, more sophisticated scales emerged. The Manchester Scar Scale (MSS) is a multi-item categorical scale, with a global scar assessment made with a visual analogue scale (VAS) (8). This scale includes descriptors of greater clinical significance, such as contour (flush, indented, hypertrophic, or keloid) as opposed to physical measurements.
- Reliability: The authors' evaluation with 69 patients showed reasonable validity and inter-rater and intra-rater reliability, but this has not yet been demonstrated in further studies.
The Vancouver Scar Scale (VSS) (9) has four variables (vascularity, height or thickness, pliability, and pigmentation) forming a numeric score from 0 to 14.
- Clinical relevance: While it is now one of more commonly-used assessment tools, it is also the most frequently-modified (10), making it difficult to assess its validity.
- Reliability: It has been shown to have acceptable internal consistency and moderate inter-rater reliability.
Tools Incorporating Patient-Reported Outcome Measures
Despite various improvements, the abovementioned scar assessment tools do not include the patient's experience and assessment. Arguably, patient function, and satisfaction are the most important clinical outcomes.
Given the importance of the patient's perspective, guidelines have now been created for the development and validation of Patient-Reported Outcome Measures (PROMs). The COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist (11, 12) includes requirements to measure properties such as clinical relevance (content validity), reliability, and responsiveness, as well as standard design requirements and preferred statistical methods.
The Patient and Observer Scar Assessment Scale (POSAS) was developed with the support of the Dutch Burn Foundation (13). The POSAS comprises of two numerical scales: the patient scores scar colour, pliability, thickness, relief, itching and pain; the observer scores scar vascularisation, pigmentation, pliability, thickness, and relief. Both scales also include a general rating of appearance.
- Clinical relevance: Using POSAS at 3 months enabled a prediction of final burn scar quality in one study (14), which can be of clinical utility.
- Reliability: The POSAS showed better internal consistency, inter-rater, and intra-rater reliability as compared to the VSS. The POSAS was then applied to linear scars and showed good internal consistency, reliability, and observer-patient agreement. When compared to the VSS in the assessment of keloid scars, the POSAS showed strong inter-rater reliability and convergent validity (15).
- Feasibility: The POSAS has also been shown to be transferrable to other cultural contexts in a few studies (16, 17).
When POSAS was first applied, an interesting divergence in the patient's and observer's general ratings was found. The total scores from patients were poorer than those from observers. The observers' opinion was significantly influenced by relief, thickness, pigmentation and colour. Conversely, scar thickness and itching significantly influenced the patients' opinion. Thickness and itching were also identified as significant factors for patients with linear scars. Pain and itching are subjective and imperceptible to the observer. There could be more factors relevant to the patient that remain invisible to the clinician and absent in scar assessment tools. Shortly after, POSAS 2.0 was created (with surface area as an additional parameter in the observer scale).
- Reliability: When tested on linear scars, this was found to have stronger reliability, and revealed similar findings to the first study (3).
- Feasibility: It is now the most frequently used CROM and PROM amongst studies of patients with burn, surgical, keloid, and necrotising fasciitis scars (10).
The subjective opinion of the patient could also be influenced by the wider context of the scar. A study on burn patients showed that patients with deeper burns had higher psychologic functioning than patients with superficial burns (18). One way to quantify holistic health is through a Health-Related Quality of Life (HRQoL) measure. The Brisbane Burn Scar Impact Profile (BBSIP) was the first HRQoL measure for paediatric and adult burn patients.
- Content validity: It was created through a relatively rigorous process of semi-structured interviews, content validation surveys, and cognitive interviews (19).
- Reliability: The proxy-report measure for patients aged zero to 8 years (BBSIP0−8) has been shown to have good longitudinal validity at baseline, 1–2 weeks and 1-month intervals (20).
The Burn-Specific Health Scale (BSHS) is a 114-item scale that quantifies dysfunction and distress across six major health domains in patients following burn injuries.
- Clinical relevance: The BSHS has been widely used and adapted across cultural contexts, suggesting clinical utility in various contexts.
- Reliability: Inter- or intra-rater reliability has not yet been demonstrated beyond initial studies (21).
- Feasibility: While comprehensive, the 114 items covered may make this scale a less feasible tool for large-scale studies conducted in outpatient settings.
Bock is a 15-item questionnaire for paediatric and adult patients with hypertrophic and keloid scars (22).
- Clinical relevance: It did not include patient input in content development, which may reduce its content validity for patients.
- Reliability: Bock has been shown to have good inter-rater reliability (23).
The Patient Scar Assessment Questionnaire (PSAQ) is a 39-item, multi-scale questionnaire for patients with linear surgical scars (24).
- Clinical relevance: PSAQ was created following qualitative patient interviews, showing some assimilation of patient input.
- Reliability: PSAQ has been shown to provide good inter-rater reliability (23).
Patient-Reported Impact of Scars Measure (PRISM) is a 37-item instrument measuring HRQoL and physical symptoms in various types of scars (25).
- Clinical relevance: PRISM demonstrated a rigorous content design and validation process by using qualitative patient data. Additionally, PRISM attempts to encompass both symptomatic and psychosocial aspects of scars.
- Reliability: PRISM has shown good intra- and inter-rater reliability (23).
Most recently, SCAR-Q has been created for children and adults with surgical, traumatic, and burn scars (26). The researchers utilised qualitative datasets to identify three key domains (scar appearance, scar symptoms, and psychosocial impact), which were subject to review through cognitive interviews with patients and feedback from clinical experts. The 29-item PROM is now being field-tested in seven clinics in four countries.
- Clinical relevance: SCAR-Q demonstrates the most rigorous content validation process.
- Reliability: Preliminary findings show good to excellent reliability (27).
Discussion
Currently, there are no assessment tools that convincingly demonstrate intra- and inter-rater reliability, validity and responsiveness to clinical changes. An overview of some of the more widely-utilised tools is shown in Tables 1A,B. Unfortunately, many of the tools described above fulfil neither the rigorous methodology nor health measurement principles required in other areas of medicine. The clinimetric properties and assessment criteria of these objective measures are summarised in Tables 1A,B, respectively.
Table 1B. Criteria of current assessment tools.
PROMs are a beneficial addition to the armamentarium of scar assessment tools. They provide the most direct measure of patient satisfaction and quality of life, and are relatively feasible to administer. However, existing instruments still have limitations. In terms of instrument content, only PRISM and SCAR-Q have demonstrated a rigorous content design and validation process by using qualitative patient data. PRISM attempts to encompass both symptomatic and psychosocial aspects of scars, but only SCAR-Q integrates scar appearance, symptoms, and psychosocial impact.
None of the PROMs available are universally applicable across clinical contexts. For example, BBSIP is only purposed for burns patients. While SCAR-Q is the first instrument designed to be applied to all scar types, the qualitative datasets used in content development did not include burn scars. POSAS has the advantage for being widely-validated and used across different scar types—this could better facilitate the development of greater consensus on significant scar features and psychosocial aspects.
On balance, SCAR-Q is a promising tool but further studies are needed to demonstrate its utility across clinical and cross-cultural contexts. The vast majority of these tools are most useful to assess large cohorts of patients both within trials and in clinical scar services. On an individual patient level, these measures must be integrated with clinical judgement, patient priorities, social factors, and a thorough multidisciplinary assessment. Validated scoring systems therefore provide an additional window into scar and patient assessment but cannot stand alone.
How to Use Scar Assessment Tools
Despite their limitations, different tools with different clinimetric qualities can still provide useful clinical information. Tyack et al. have published a guide to choosing a burn scar rating scale for clinical or research use (28). Figure 1 provides a concise algorithm to guide the selection of an appropriate scar assessment tool.
Figure 1. A proposed guide to how to use currently available scar assessment tools.
Purpose of the Study
Objective scar measurements could be used to monitor benefits of scar treatment, by providing proxies to biological changes occurring within tissue. This may be useful for research on scar therapies. However, the scar's physical attributes may be less relevant for studying patients' psychosocial health, which may be a focus of clinical studies. Lawrence et al. (29) examined the relationship among burn scarring, severity and visibility, and body esteem (29). The visibility of scarring was unrelated to self-satisfaction. When multiple regression analysis for predicting body esteem was performed, burn characteristics accounted for <20% of the variance. Conversely, social adjustment and depression accounted for the most variance. Hence, PROMs may provide a better measure of psychosocial health and HRQoL. In particular, POSAS can reflect changes in HRQoL over time. This can help clinicians evaluate the psychosocial health of their patients as they progress in their physical recovery.
Target Population Characteristics
Many of the scales have yet to be assessed in other cultural and/or ethnic contexts, although POSAS has been demonstrated to be transferable to other cultural populations (16, 17). Only a few measures (BBSIP and Bock) have been validated in paediatric populations. Other tools may be less accessible to a paediatric population.
The context of the scar may also be important. Scars caused by accidents and assault usually have greater psychological impact (30). These patients can experience higher scores on the General Self-Consciousness (GSC) scale as compared to patients with sports-related facial scars (31). Thus, both objective and subjective assessments may be required for a holistic representation of patient health. Burn scars may present unique challenges in restoring appearance, function and quality of life, so it may be appropriate to employ a burn-specific assessment tool. However, it has not yet been shown if burn-specific measures like BSHS and BBSIP are superior to POSAS (which has been applied to burn scars).
Feasibility
In low-resource settings, highly specialised, or costly tools (including spectrophotometry and stereophotogrammetry) are unfeasible. CROMs and PROMs can be easily administered within an outpatient clinic setting. For example, POSAS is reported to take <5 min to administer (28). However, PROMs are unfeasible when patients are unconscious, unable to understand or complete questionnaires.
Conclusions
A patient with a scar does not only see measurable characteristics (pigmentation, thickness, length, etc.) but also experiences unseen discomforts (like itch and pain). There may be sequelae such as self-consciousness, loss of identity, isolation, and depression. How others evaluate the scar can also contribute to the patient's psychosocial health. Unfortunately, these factors have yet to be fully assimilated into scar assessment tools. More qualitative studies are needed to understand the patient's experience of scarring. A greater synthesis of the quantitative and qualitative is needed, so as to produce a comprehensive and holistic assessment. Tools need to be meaningfully applied in the appropriate contexts to help direct treatment, monitor scar evolution, and allow the robust evaluation of therapies. Additionally, these tools need to be rigorously tested for validity and responsiveness, so that they will provide a common platform to engage in academic and clinical discussion.
Author Contributions
AC conducted the literature review and drafted the submission. YO and FI oversaw the editing process. All authors contributed to the paper and approved the final submission.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fsurg.2021.643098/full#supplementary-material
References
1. Williams NS, O'Connell PR, McCaskie AW. Bailey & Love's Short Practice of Surgery. 27 ed. CRC Press (2018).
2. Ferguson MWJ, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT. Scar formation: the spectral nature of wound repair. Plast Reconstr Surg. (1996) 97:854–60. doi: 10.1097/00006534-199604000-00029
3. van de Kar AL, Corion LUM, Smeulders MJC, Draaijers LJ, van der Horst CMAM, van Zuijlen PPM. Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg. (2005) 116:514–22. doi: 10.1097/01.prs.0000172982.43599.d6
4. Durani P, McGrouther DA, Ferguson MWJ. Current scales for assessing human scarring: a review. J Plast Reconstr Aesthetic Surg. (2009) 62:713–20. doi: 10.1016/j.bjps.2009.01.080
5. Verhaegen PDHM, van der Wal MBA, Middelkoop E, van Zuijlen PPM. Objective scar assessment tools: a clinimetric appraisal. Plast Reconstr Surg. (2011) 127:1561–70. doi: 10.1097/PRS.0b013e31820a641a
6. Smith GM, Tompkins DM, Bigelow ME, Antoon AY. Burn-induced cosmetic disfigurement: can it be measured reliably? J Burn Care Rehabil. (1988) 9:371–5. doi: 10.1097/00004630-198807000-00011
7. Hollander JE, Singer AJ, Valentine S, Henry MC. Wound registry: development and validation. Ann Emerg Med. (1995) 25:675–84. doi: 10.1016/S0196-0644(95)70183-4
8. Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. (1998) 102:1954–61. doi: 10.1097/00006534-199811000-00022
9. Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ. Rating the burn scar. J Burn Care Rehabil. (1990) 11:256–60. doi: 10.1097/00004630-199005000-00014
10. Carrire ME, Kwa KAA, de Haas LEM, Pijpe A, Tyack Z, Thy BO, et al. Systematic review on the content of outcome measurement instruments on scar quality. plastic and reconstructive surgery. Global Open. (2019) 7:e2424. doi: 10.1097/GOX.0000000000002424
11. Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, et al. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. (2002) 11:193–205. doi: 10.1023/a:1015291021312
12. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. (2010) 19:539. doi: 10.1007/s11136-010-9606-8
13. Draaijers LJ, Tempelman FRH, Botman YAM, Tuinebreijer WE, Middelkoop E, Kreis RW, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. (2004) 113:1960–5. doi: 10.1097/01.PRS.0000122207.28773.56
14. Goei H, van der Vlies CH, Tuinebreijer WE, van Zuijlen PPM, Middelkoop E, van Baar ME. Predictive validity of short term scar quality on final burn scar outcome using the Patient and Observer Scar Assessment Scale in patients with minor to moderate burn severity. Burns. (2017) 43:715–23. doi: 10.1016/j.burns.2016.10.012
15. Nicholas RS, Falvey H, Lemonas P, Damodaran G, Ghannem A, Selim F, et al. Patient-Related keloid scar assessment and outcome measures. Plast Reconstr Surg. (2012) 129:648–56. doi: 10.1097/PRS.0b013e3182402c51
16. Seyyah M, Yurdalan SU. Cultural adaptation and validation of Patient and Observer Scar Assessment Scale for Turkish use. Burns. (2018) 44:1352–6. doi: 10.1016/j.burns.2018.02.026
17. Vercelli S, Ferriero G, Bravini E, Stissi V, Ciceri M, Rossetti S, et al. Cross-cultural adaptation, reproducibility and validation of the Italian version of the Patient and Observer Scar Assessment Scale (POSAS). Int Wound J. (2017) 14:1262–8. doi: 10.1111/iwj.12795
18. Baker RAU, Jones S, Sanders C, Sadinski C, Martin-Duffy K, Berchin H, et al. Degree of burn, location of burn, and length of hospital stay as predictors of psychosocial status and physical functioning. J Burn Care Rehabil. (1997) 17:327–33. doi: 10.1097/00004630-199607000-00008
19. Tyack Z, Ziviani J, Kimble R, Plaza A, Jones A, Cuttle L, et al. Measuring the impact of burn scarring on health-related quality of life: development and preliminary content validation of the Brisbane Burn Scar Impact Profile (BBSIP) for children and adults. Burns. (2015) 41:1405–19. doi: 10.1016/j.burns.2015.05.021
20. Simons M, Kimble R, McPhail S, Tyack Z. The longitudinal validity, reproducibility and responsiveness of the Brisbane Burn Scar Impact Profile (caregiver report for young children version) for measuring health-related quality of life in children with burn scars. Burns. (2019) 45:1792–809. doi: 10.1016/j.burns.2019.04.015
21. Spronk IL, Legemate C, Oen I, van Loey N, Polinder S, van Baar M. Health related quality of life in adults after burn injuries: a systematic review. PLoS ONE. (2018) 13:e0197507. doi: 10.1371/journal.pone.0197507
22. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. (2006) 297:433–8. doi: 10.1007/s00403-006-0651-7
23. Mundy LR, Miller HC, Klassen AF, Cano SJ, Pusic AL. Patient-reported outcome instruments for surgical and traumatic scars: a systematic review of their development, content, psychometric validation. Aesthetic Plast Surg. (2016) 40:792–800. doi: 10.1007/s00266-016-0642-9
24. Durani P, McGrouther DA, Ferguson MW. The patient scar assessment questionnaire: a reliable and valid patient-reported outcomes measure for linear scars. Plast Reconstr Surg. (2009) 123:1481–9. doi: 10.1097/PRS.0b013e3181a205de
25. Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A. The patient-reported impact of scars measure: development and validation. Plast Reconstr Surg. (2010) 125:1439–49. doi: 10.1097/PRS.0b013e3181d4fd89
26. Anne FK, Ziolkowski N, Mundy LR, Miller HC, McIlvride A, DiLaura A, et al. Development of a new patient-reported outcome instrument to evaluate treatments for scars: the SCAR-Plastic Q. Plast Reconstr Surg Glob Open. (2018). 6:e1672. doi: 10.1097/GOX.0000000000001672
27. Natalia Z, Pusic A, Fish JS, Mundy LR, She RW, Forrest CR, et al. Abstract 94: SCAR-Q: international results and why individuals report the need for scar revision surgery. Plast Reconstr Surg Global Open. (2019) 7:65–6. doi: 10.1097/01.GOX.0000558368.69282.07
28. Tyack Z, Wasiak J, Spinks A, Kimble R, Simons M. A guide to choosing a burn scar rating scale for clinical or research use. Burns. (2013) 39:1341–50. doi: 10.1016/j.burns.2013.04.021
29. Lawrence JW, Fauerbach JA, Heinberg L. Visible vs Hidden Scars and Their Relation to Body Esteem. J of Burn Care & Rehabilitation. (2004) 25:25–32.
30. Shepherd JP, Qureshi R, Preston MS, Levers BG. Psychological distress after assaults and accidents. Br Med J. (1990) 301:849–50. doi: 10.1136/bmj.301.6756.849
31. Tebble NJ, Adams R, Thomas DW, Price P. Anxiety and self-consciousness in patients with facial lacerations one week and six months later. Br J Oral Maxillofacial Surg. (2006) 44:520–5. doi: 10.1016/j.bjoms.2005.10.010
32. Draaijers LJ, Tempelman FRH, Botman YAM, Kreis RW, Middelkoop E, van Zuijlen PPM. Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation? Burns. (2004) 30:103–7. doi: 10.1016/j.burns.2003.09.029
33. Lévêque JL. EEMCO guidance for the assessment of skin topography. J Europ Acad Dermatol Venereol. (1999) 12:103–14. doi: 10.1016/S0926-9959(98)00094-4
34. Lau JCM, Li-Tsang CWP, Zheng YP. Application of tissue ultrasound palpation system (TUPS) in objective scar evaluation. Burns. (2005) 31:445–52. doi: 10.1016/j.burns.2004.07.016
35. Meaume S, Humbert P. Skin Wound Healing Assessment. Cham: Springer. (2017). p. 503–12. doi: 10.1007/978-3-319-32383-1_54
Keywords: clinician reported outcomes, surgical scar, burn scar assessment, scar assessment, patient reported outcome, linear scars
Citation: Choo AMH, Ong YS and Issa F (2021) Scar Assessment Tools: How Do They Compare? Front. Surg. 8:643098. doi: 10.3389/fsurg.2021.643098
Received: 17 December 2020; Accepted: 20 May 2021;
Published: 23 June 2021.
Edited by:
Jan A. Plock, University of Zurich, SwitzerlandReviewed by:
Oren Lapid, Academic Medical Center, NetherlandsPaul Van Zuijlen, Red Cross Hospital, Netherlands
Copyright © 2021 Choo, Ong and Issa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amanda Min Hui Choo, amandachoominhui95@yahoo.com